4.5 Article

An interplay between non-coding RNAs and gut microbiota in human health

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Prediction of type 2 diabetes mellitus using hematological factors based on machine learning approaches: a cohort study analysis

Amin Mansoori et al.

Summary: Type 2 Diabetes Mellitus is a global public health problem. This study aimed to assess the association between hematological parameters and T2DM. Machine learning techniques were used for data analysis and the results showed that age and white blood cell count were the most effective factors in predicting T2DM.

SCIENTIFIC REPORTS (2023)

Review Microbiology

Gut Microbiota-MicroRNA Interactions in Intestinal Homeostasis and Cancer Development

Nataliia Nikolaieva et al.

Summary: Pre-clinical models and clinical studies have shown that the host-microbiota relationship has a significant impact on cancer development and treatment, leading to the emergence of a microbiota-based approach in clinical oncology. Polymorphic microbes are considered a hallmark of cancer, and microRNAs play a crucial role in gene expression regulation. Bidirectional gut microbiota-microRNA interactions have been found to be important for intestinal homeostasis and are associated with inflammatory responses and dysbiosis in gastrointestinal disorders. This review summarizes the current understanding of miRNA expression in the intestine, with a focus on gut microbiota-miRNA interactions related to intestinal homeostasis, the immune system, and cancer development. The potential clinical utility of fecal miRNA profiling as a diagnostic and prognostic tool in colorectal cancer is discussed, as well as the potential of gut microbiota modulation and personalized microRNA therapeutics in improving outcomes for patients with gastrointestinal cancer in the era of precision medicine.

MICROORGANISMS (2023)

Review Oncology

MicroRNA-122 in human cancers: from mechanistic to clinical perspectives

Mahboobeh Faramin Lashkarian et al.

Summary: MicroRNAs (miRNAs) are short non-coding RNAs that regulate gene expression and interact with mRNA-coding genes. Abnormal miRNA expression has been linked to various diseases, including cancer. Several miRNAs, such as miR-122, miR-206, miR-21, miR-210, miR-223, and miR-424, have been extensively studied in different types of cancer. Despite significant progress in miRNA research, there is still much to discover, particularly in the context of cancer therapies. The dysregulation and abnormal expression of miR-122 have been associated with multiple types of cancer, suggesting its potential as a diagnostic or prognostic biomarker. This review focuses on analyzing the role of miR-122 in various cancer types and its impact on patient response to standard therapy.

CANCER CELL INTERNATIONAL (2023)

Article Cell Biology

MiR-211 plays a dual role in cancer development: From tumor suppressor to tumor enhancer

Hanieh Shirvani et al.

Summary: This review discusses the expression levels, target genes, and mechanisms of miR-211 in different cancers, revealing its oncogenic or tumor-suppressive impact on tumorigenesis and cancer development. Additionally, miR-211 may serve as a noninvasive biomarker and therapeutic factor for the diagnosis and treatment of cancer.

CELLULAR SIGNALLING (2023)

Review Biochemistry & Molecular Biology

MiR-155: An Important Regulator of Neuroinflammation

Valeria Domenica Zingale et al.

Summary: miRNAs, small non-coding RNA molecules, play a crucial role in the development of neurological diseases by regulating gene expression. Imbalance in miRNAs expression pattern may lead to the occurrence of neurological disorders. Modulation of miRNAs expression could be utilized as a therapeutic strategy in treating pathological neuroinflammation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Neurosciences

Integrative Analysis of Long Non-coding RNAs, Messenger RNAs, and MicroRNAs Indicates the Neurodevelopmental Dysfunction in the Hippocampus of Gut Microbiota-Dysbiosis Mice

Lanxiang Liu et al.

Summary: This study investigates the role of the gut microbiota in major depressive disorder (MDD) and identifies dysregulated genes and pathways associated with MDD. The results show that dysbiosis of the gut microbiota leads to differential expression of mRNA, lncRNA, and miRNA in the hippocampus of mice. Functional analysis reveals that dysregulated inflammatory response and neurodevelopmental processes are key pathological changes in MDD. Moreover, a microbial-regulated lncRNA-miRNA-mRNA network is constructed, highlighting the potential genetic and epigenetic biomarkers for microbial-associated depression. This study sheds light on the pathogenesis of MDD and provides insights for the development of gut microbiota-based antidepressants.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2022)

Article Microbiology

Fecal microbiota transplantation as tool to study the interrelation between microbiota composition and miRNA expression

Koen Wortelboer et al.

Summary: The gut microbiota and secreted miRNAs have an interaction, and changes in the microbiota can affect the composition of secreted miRNAs.

MICROBIOLOGICAL RESEARCH (2022)

Article Nutrition & Dietetics

Supplementation with Milk-Derived Extracellular Vesicles Shapes the Gut Microbiota and Regulates the Transcriptomic Landscape in Experimental Colitis

Chunmei Du et al.

Summary: This study found that milk-derived extracellular vesicles (EVs) can attenuate colitis by optimizing the abundance of gut microbiota and manipulating intestinal gene expression, suggesting their potential application for colitis prevention.

NUTRIENTS (2022)

Article Gastroenterology & Hepatology

The gut microbiota mediates protective immunity against tuberculosis via modulation of lncRNA

Fang Yang et al.

Summary: The gut-lung axis plays a critical role in lung disorders, including tuberculosis. This study identified a gut commensal bacteria-regulated lncRNA called lncRNA-CGB that is down-regulated during TB infection. The oral administration of Bacteroides fragilis promoted the expression of lncRNA-CGB and enhanced anti-TB immunity. Mechanistically, lncRNA-CGB interacted with EZH2 and regulated the epigenetic programming of IFN-gamma expression. These findings highlight the importance of the gut bacteria-lncRNA-EZH2-H3K27Me3 axis in immune protection against TB and provide a potential new approach for microbiota-based TB treatment.

GUT MICROBES (2022)

Review Biochemistry & Molecular Biology

Non-coding RNA in SARS-CoV-2: Progress toward therapeutic significance

Hanieh Shirvani et al.

Summary: This article presents the molecular biology of SARS-CoV-2, the role of noncoding RNAs in its infection, and various RNA therapy tactics against the virus.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Article Endocrinology & Metabolism

Progress toward molecular therapy for diabetes mellitus: A focus on targeting inflammatory factors

Mohadesse Dehghan et al.

Summary: Diabetes mellitus is a prevalent metabolic disease with inflammation and immunity playing important roles in its pathogenesis. Although chemical agents are available for treatment, new targeted molecular therapies are needed to improve clinical outcomes.

DIABETES RESEARCH AND CLINICAL PRACTICE (2022)

Review Biochemistry & Molecular Biology

Long non-coding RNAs: a valuable biomarker for metabolic syndrome

Mohammad Rashidmayvan et al.

Summary: Long non-coding RNAs (lncRNAs) have emerged as important regulators of gene expression, influencing various biological processes such as cell growth, death, differentiation, and aging. Evidence suggests that imbalances in lncRNAs play a role in metabolic disorders including diabetes, obesity, and heart disease. This review focuses on the understanding of how lncRNAs control metabolism, particularly in diseases caused by chronic inflammation and metabolic syndrome. The potential of lncRNAs as diagnostic and therapeutic targets for improving metabolic homeostasis is also discussed.

MOLECULAR GENETICS AND GENOMICS (2022)

Review Oncology

Long non-coding RNAs (lncRNAs); roles in tumorigenesis and potentials as biomarkers in cancer diagnosis

Sajad Najafi et al.

Summary: New research has shown that long non-coding RNAs (lncRNAs) play crucial roles in various biological processes, including the development of complex human diseases like cancer. Although the specific regulation mechanisms of many lncRNAs in cancer are still unknown, a few have been identified. This study provides a summary of recent advances in understanding the mechanisms and functions of lncRNAs in cancer, with a focus on their roles as oncogenes and tumor suppressors, as well as their potential use as biomarkers for cancer diagnosis and prognosis.

EXPERIMENTAL CELL RESEARCH (2022)

Article Gastroenterology & Hepatology

F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer

Jie Hong et al.

Summary: The study revealed a positive correlation between Fusobacterium nucleatum and high glucose metabolism in patients with colorectal cancer (CRC), suggesting a potential role of gut microbiota in CRC development. Mechanistically, Fusobacterium nucleatum activated the lncRNA ENO1-IT1 pathway to regulate CRC cell glucose metabolism and biological functions. Targeting the ENO1 pathway may have therapeutic implications for CRC patients with elevated Fusobacterium nucleatum levels.
Review Biochemistry & Molecular Biology

Noncoding RNAs: Regulatory Molecules of Host-Microbiome Crosstalk

Nilusha Malmuthuge et al.

Summary: Regulatory noncoding RNAs such as microRNAs and circular RNAs modulate host-microbe interactions and have been proposed as potential biomarkers of microbiome-linked pathologies. However, their interactions increase complexity and application to larger animals and humans poses challenges.

TRENDS IN MICROBIOLOGY (2021)

Article Multidisciplinary Sciences

Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy

Taraprasad Das et al.

Summary: The study reveals dysbiosis in the gut microbiome of patients with DR compared to healthy controls, with a decrease in anti-inflammatory and probiotic bacteria. This dysbiosis may impact the treatment of DR and warrants further investigation for developing targeted therapies.

SCIENTIFIC REPORTS (2021)

Review Medicine, Research & Experimental

Extracellular vesicle-derived miRNA as a novel regulatory system for bi-directional communication in gut-brain-microbiota axis

Liang Zhao et al.

Summary: This review discusses the potential functional link between EV-derived microRNAs and GBMAx, proposing that EV-derived microRNAs may serve as a novel regulatory system for GBMAx and a potential therapeutic target for modifying GBMAx in clinical therapy.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

Article Medicine, Research & Experimental

Probiotic-prebiotic-synbiotic modulation of (YAP1, LATS1 and NF2 mRNAs/miR-1205/lncRNA SRD5A3-AS1) panel in NASH animal model

Shaimaa H. Gadallah et al.

Summary: The prophylactic efficacy of gut microbiota-based treatments on nonalcoholic steatohepatitis (NASH) management was investigated through modulation of Hippo signaling pathway-related genes and their epigenetic regulators. Both probiotic mixture and prebiotic inulin fiber attenuated steatosis, inflammation, and fibrosis in NASH rats induced by a high sucrose high fat diet. The treatments also led to improvements in liver function and modulation of RNA panel related to NASH progression.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Microbiology

Maternal cecal microbiota transfer rescues early-life antibiotic-induced enhancement of type 1 diabetes in mice

Xue-Song Zhang et al.

Summary: Early-life antibiotic exposure disrupts the intestinal microbiota and accelerates type 1 diabetes development in the NOD mouse model. Maternal cecal microbiota transfer after early-life antibiotic perturbation can largely rescue the induced type 1 diabetes enhancement, restoring the intestinal microbiome and protecting against perturbed metabolites and normalized immune effectors. Further experiments suggest a gut-microbiota-regulated type 1 diabetes protection mechanism.

CELL HOST & MICROBE (2021)

Article Multidisciplinary Sciences

Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with pre-diabetes and type 2 diabetes mellitus: A case control study

Fahime Zeinali et al.

Summary: The study investigates the differential expression of miRNAs in T2DM and pre-diabetic patients, suggesting potential roles of miRNAs in the pathogenesis of T2DM. Positive correlations were found between miRNA-122 and inflammatory factors as well as insulin resistance, while negative correlations were observed between miRNA-126-3p and miRNA-146a levels with these factors. Further studies are needed to validate these findings.

PLOS ONE (2021)

Article Ophthalmology

Dysbiosis in the Gut Microbiome in Streptozotocin-Induced Diabetes Rats and Follow-Up During Retinal Changes

Shalem Raj Padakandla et al.

Summary: The gut bacterial microbiome of diabetic rats with retinal changes showed dysbiosis compared to control rats at phylum and genus levels. This study could potentially lead to the development of novel therapeutics for diabetic individuals with retinal changes.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2021)

Article Biotechnology & Applied Microbiology

Comprehensive analysis of lncRNA-miRNA-mRNA regulatory networks for microbiota-mediated colorectal cancer associated with immune cell infiltration

Xiangzhou Tan et al.

Summary: Recent research has identified microbiota as crucial players in various disease conditions, including cancers, with ceRNA mechanisms playing a role in these biological processes. By constructing ceRNA networks using TCGA and GEO databases, potential mechanisms of microbiota-mediated colorectal carcinogenesis and progression were explored. The study revealed two distinct ceRNA networks associated with metabolic processes and unique pathways, as well as suggesting prognostic factors, lncRNAs linked to survival outcomes, and potential anticancer drugs. Additionally, a gene signature significantly correlated with immune infiltration levels was identified, providing insight into how microbiota regulate ceRNA networks and impact colorectal cancer development.

BIOENGINEERED (2021)

Article Multidisciplinary Sciences

Coronary artery disease is associated with an altered gut microbiome composition

Takumi Toya et al.

PLOS ONE (2020)

Article Gastroenterology & Hepatology

Gut microbiota regulate tumor metastasis via circRNA/miRNA networks

Zhuxian Zhu et al.

GUT MICROBES (2020)

Article Medicine, Research & Experimental

Microbiota Imbalance Contributes to COPD Deterioration by Enhancing IL-17a Production via miR-122 and miR-30a

Ke Zhu et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

Review Biochemistry & Molecular Biology

The roles of the gut microbiota-miRNA interaction in the host pathophysiology

Meihong Li et al.

MOLECULAR MEDICINE (2020)

Article Gastroenterology & Hepatology

Host miRNA-21 promotes liver dysfunction by targeting small intestinal Lactobacillus in mice

Andre A. Santos et al.

GUT MICROBES (2020)

Review Microbiology

The Human Microbiome and Its Impacts on Health

Grace A. Ogunrinola et al.

INTERNATIONAL JOURNAL OF MICROBIOLOGY (2020)

Review Medicine, General & Internal

Major miRNA Involved in Insulin Secretion and Production in Beta-Cells

Mohsen Aghaei et al.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2020)

Review Food Science & Technology

Revisit gut microbiota and its impact on human health and disease

Rui-xue Ding et al.

JOURNAL OF FOOD AND DRUG ANALYSIS (2019)

Review Biochemistry & Molecular Biology

The Influence of Diet on MicroRNAs that Impact Cardiovascular Disease

Branislav Kura et al.

MOLECULES (2019)

Article Immunology

Dysbiosis of the Gut Microbiome in Lung Cancer

He Zhuang et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)

Article Cell Biology

The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs

Anthony T. Virtue et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Article Genetics & Heredity

Gut Microbiota Composition Is Associated With the Global DNA Methylation Pattern in Obesity

Bruno Ramos-Molinau et al.

FRONTIERS IN GENETICS (2019)

Article Endocrinology & Metabolism

The Gut Microbiome, Lactobacillus acidophilus; Relation with Type 2 Diabetes Mellitus

Mohamed R. Halawa et al.

CURRENT DIABETES REVIEWS (2019)

Article Gastroenterology & Hepatology

Loss of MicroRNA-21 Influences the Gut Microbiota, Causing Reduced Susceptibility in a Murine Model of Colitis

Daniel G. W. Johnston et al.

JOURNAL OF CROHNS & COLITIS (2018)

Article Multidisciplinary Sciences

A taxonomic signature of obesity in a large study of American adults

Brandilyn A. Peters et al.

SCIENTIFIC REPORTS (2018)

Article Microbiology

Plant-Derived Exosomal MicroRNAs Shape the Gut Microbiota

Yun Teng et al.

CELL HOST & MICROBE (2018)

Article Peripheral Vascular Disease

Systolic and diastolic blood pressure percentiles by age and gender in Northeastern Iran

Maryam Tayefi et al.

JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2018)

Article Biochemistry & Molecular Biology

Commensal microbiota-induced microRNA modulates intestinal epithelial permeability through the small GTPase ARF4

Kazuaki Nakata et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

Meeting Abstract Cardiac & Cardiovascular Systems

HOST INTESTINAL EPITHELIUM DERIVED MIRNAS SHAPE THE MICROBIOTA AND ITS IMPLICATION IN CARDIOVASCULAR DISEASES

Lianbi Zhao et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Multidisciplinary Sciences

The gut microbiome in atherosclerotic cardiovascular disease

Zhuye Jie et al.

NATURE COMMUNICATIONS (2017)

Article Cardiac & Cardiovascular Systems

MiR-155 Knockout in Fibroblasts Improves Cardiac Remodeling by Targeting Tumor Protein p53-Inducible Nuclear Protein 1

Wangwei He et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2016)

Article Biochemistry & Molecular Biology

Diet-Microbiota Interactions Mediate Global Epigenetic Programming in Multiple Host Tissues

Kimberly A. Krautkramer et al.

MOLECULAR CELL (2016)

Review Genetics & Heredity

Circular RNA Expression: Its Potential Regulation and Function

Julia Salzman

TRENDS IN GENETICS (2016)

Review Oncology

The dual regulatory role of miR-204 in cancer

Tianqi Li et al.

TUMOR BIOLOGY (2016)

Editorial Material Multidisciplinary Sciences

Microbiome Engineering

Justin L. Sonnenberg

NATURE (2015)

Article Biotechnology & Applied Microbiology

Site-specific programming of the host epithelial transcriptome by the gut microbiota

Felix Sommer et al.

GENOME BIOLOGY (2015)

Article Oncology

The Human Gut Microbiome as a Screening Tool for Colorectal Cancer

Joseph P. Zackular et al.

CANCER PREVENTION RESEARCH (2014)

Review Gastroenterology & Hepatology

Recent advances in transport of water-soluble vitamins in organs of the digestive system: a focus on the colon and the pancreas

Hamid M. Said

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)

Article Oncology

Human Gut Microbiome and Risk for Colorectal Cancer

Jiyoung Ahn et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)